新光药业(300519.SZ)股东和丰投资拟合计减持不超3%股份

Core Viewpoint - The company Shinkong Pharmaceutical (300519.SZ) announced that its shareholder, Shengzhou Hefeng Investment Co., Ltd. ("Hefeng Investment"), plans to reduce its holdings by up to 4.8 million shares, representing no more than 3% of the company's total share capital within three months after the announcement date [1] Group 1 - Hefeng Investment intends to execute the share reduction through centralized bidding or block trading methods [1] - The reduction will take place within a timeframe of three months starting from 15 trading days after the announcement [1]